Head & Neck Cancer Treatment: Complete Clinical Guide, Benefits & Recovery

Clinical Overview: Understanding Head & Neck Cancer Treatment

Head & Neck Cancer Treatment represents a cornerstone clinical program at Spica Healthcare — Grover Hospital, Bathinda. Supervised directly by Dr. Neha Gupta (Director & Senior Medical Oncologist), this evidence-based pathway integrates sub-millimeter surgical precision, advanced intraoperative 3D navigation, ISO Class-100 Laminar Airflow surgical suites, and personalized accelerated rehabilitation to restore function, eliminate pain, and maximize long-term treatment longevity.

In South-Western Punjab and adjoining regions of Haryana and Rajasthan, patients frequently encounter delayed clinical diagnoses or generalized approaches that fail to address anatomical nuances. At Spica Healthcare, every patient undergoes rigorous digital staging, ensuring that surgical interventions or targeted medical therapies are customized to individual biomechanics and oncological requirements.

Clinical Indications: When is Head & Neck Cancer Treatment Recommended?

• Squamous cell carcinoma of the oral cavity (buccal mucosa, tongue, floor of mouth, retromolar trigone).

• Oropharyngeal cancer (tonsil, base of tongue) requiring HPV/p16 testing and organ-preserving therapy.

• Laryngeal and hypopharyngeal cancer requiring voice-preserving concurrent chemoradiation.

• Recurrent or metastatic head and neck cancer requiring first-line Pembrolizumab immunotherapy.

Step-by-Step Surgical & Clinical Pathway at Grover Hospital

Step 1: Endoscopic Staging & PET-CT

Flexible video nasopharyngolaryngoscopy (NPL), biopsy, and whole-body FDG PET-CT scan.

Step 2: HPV & Biomarker Profiling

p16 IHC testing for HPV status, PD-L1 CPS scoring, and multidisciplinary tumor board review.

Step 3: Definitive Multimodal Oncology

Execution of definitive organ-preserving chemoradiation or surgical resection with microvascular free flap.

Step 4: Swallowing Rehab & Follow-Up

Dedicated speech and swallowing therapy, enteral nutritional support, and regular follow-up.

Director's Signature Innovation: Comprehensive Multimodal Head & Neck Cancer Treatment

Dr. Neha Gupta coordinates multidisciplinary Head & Neck Oncology care for cancers of the oral cavity, tongue, pharynx, larynx (voice box), and salivary glands. Utilizing HPV/p16 status biomarker testing, organ-preserving concurrent chemoradiotherapy (preserving natural voice and swallowing), targeted anti-EGFR therapy (Cetuximab), and first-line checkpoint immunotherapy (Pembrolizumab ± Platinum-5-FU / KEYNOTE-048 protocol) for recurrent/metastatic disease, patients achieve high cure rates while preserving speech and facial appearance.

✔ Voice-Preserving Chemoradiation: Spares the natural larynx (voice box) in locally advanced laryngeal cancer

✔ HPV/p16 Biomarker Profiling: Identifies highly treatment-responsive HPV-associated oropharyngeal cancers

✔ First-Line Immunotherapy (Pembrolizumab): Proven overall survival extension in recurrent/metastatic disease

✔ Speech & Swallowing Rehabilitation: Dedicated rehabilitation maintaining nutrition and vocal clarity

Recovery Timeline & Functional Milestones

Phase 1: Diagnostic Staging & Dental Prep (Day 1 – 7)

Endoscopic biopsy, contrast CT neck/thorax or whole-body PET-CT, and dental/nutritional evaluation.

Phase 2: Definitive Treatment Phase (Month 1 – 2)

Organ-preserving concurrent chemoradiotherapy in Daycare suite or wide surgical resection with flap reconstruction.

Phase 3: Speech & Swallowing Recovery (Month 3 – 4)

Swallowing and speech therapy, resolution of acute radiation mucositis, and dietary normalization.

Phase 4: Long-Term Survivorship (Month 6 – Long Term)

Routine clinical and endoscopic surveillance, thyroid function checks, and long-term remission monitoring.

Frequently Asked Clinical Questions (FAQs)

Can throat and voice box cancer be cured without losing my voice?

Yes. For cancers of the larynx (voice box) and pharynx, modern concurrent chemoradiotherapy cures the cancer while preserving your natural vocal cords and speech, avoiding complete voice box removal surgery (total laryngectomy) in the vast majority of patients.

What is HPV-related head and neck cancer and how does it affect prognosis?

HPV (Human Papillomavirus) is an increasingly common cause of tonsil and base-of-tongue cancers. HPV-positive cancers have a significantly better prognosis and respond much more favorably to treatment than traditional tobacco-related cancers, allowing tailored, less toxic treatment protocols.

Is Head and Neck Cancer Treatment cashless under Ayushman Bharat?

Yes, head and neck cancer surgeries, microvascular reconstructions, chemoradiation protocols, immunotherapy, and inpatient care at Grover Hospital Bathinda are covered 100% cashless under PM-JAY Ayushman Bharat and 30+ private TPAs.

100% Cashless Insurance & PM-JAY Ayushman Bharat Empanelment

At Spica Healthcare — Grover Hospital Bathinda, Head & Neck Cancer Treatment is fully covered under the Government of India's PM-JAY Ayushman Bharat scheme and over 30+ leading private insurance TPAs. Our on-campus insurance coordinator handles all pre-authorization documentation directly with your insurance company, eliminating financial delays. Families can also share digital DICOM CDs and biopsy reports via WhatsApp (+91 95013 73003) for an urgent surgical review.